Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.028 | 1 | 1 |
Toxoplasma gondii | Sodium:neurotransmitter symporter family protein | 0.0037 | 0 | 0.5 |
Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.0217 | 0.7408 | 0.7408 |
Loa Loa (eye worm) | hypothetical protein | 0.0217 | 0.7408 | 0.7408 |
Schistosoma mansoni | sodium/chloride dependent transporter | 0.0217 | 0.7408 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0217 | 0.7408 | 0.7408 |
Loa Loa (eye worm) | solute carrier family 6 member 4 | 0.0217 | 0.7408 | 0.7408 |
Toxoplasma gondii | hypothetical protein | 0.0037 | 0 | 0.5 |
Plasmodium vivax | amine transporter, putative | 0.0037 | 0 | 0.5 |
Toxoplasma gondii | hypothetical protein | 0.0037 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0217 | 0.7408 | 0.7408 |
Onchocerca volvulus | Bile acid receptor homolog | 0.028 | 1 | 1 |
Treponema pallidum | sodium- and chloride- dependent transporter | 0.0217 | 0.7408 | 0.5 |
Onchocerca volvulus | 0.0217 | 0.7408 | 0.7408 | |
Schistosoma mansoni | norepinephrine/norepinephrine transporter | 0.0217 | 0.7408 | 1 |
Chlamydia trachomatis | Ssodium-dependent amino acid transporter | 0.0037 | 0 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0037 | 0 | 0.5 |
Loa Loa (eye worm) | norepinephrine transporter | 0.0217 | 0.7408 | 0.7408 |
Echinococcus multilocularis | serotonin transporter | 0.0217 | 0.7408 | 1 |
Loa Loa (eye worm) | serotonin transporter b | 0.0217 | 0.7408 | 0.7408 |
Plasmodium falciparum | amino acid transporter, putative | 0.0037 | 0 | 0.5 |
Toxoplasma gondii | Sodium:neurotransmitter symporter family protein | 0.0037 | 0 | 0.5 |
Echinococcus granulosus | serotonin transporter | 0.0217 | 0.7408 | 1 |
Toxoplasma gondii | Sodium:neurotransmitter symporter family protein | 0.0037 | 0 | 0.5 |
Plasmodium falciparum | transporter, putative | 0.0037 | 0 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.